Virginie Pécourneau1, Yannick Degboé2, Thomas Barnetche3, Alain Cantagrel1, Arnaud Constantin2, Adeline Ruyssen-Witrand4. 1. Rheumatology Center, Purpan Teaching Hospital, Toulouse, France; Toulouse III University - Paul Sabatier, Toulouse, France. 2. Rheumatology Center, Purpan Teaching Hospital, Toulouse, France; Toulouse III University - Paul Sabatier, Toulouse, France; UMR 1043, INSERM, Toulouse, France. 3. Rheumatology Department, Pellegrin Tripode Teaching Hospital, Bordeaux, France. 4. Rheumatology Center, Purpan Teaching Hospital, Toulouse, France; Toulouse III University - Paul Sabatier, Toulouse, France; UMR1027, Inserm, Toulouse, France. Electronic address: ruyssen-witrand.a@chu-toulouse.fr.
Abstract
OBJECTIVE: To assess the effectiveness of exercise programs on disease activity and function in ankylosing spondylitis (AS) by a systematic review and meta-analysis of randomized controlled trials (RCTs). DATA SOURCES: Medline via PubMed and Cochrane Library. STUDY SELECTION: Reports of RCTs examining the effectiveness of exercise programs for AS published up to May 2017. DATA EXTRACTION: Outcomes were evolution of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) after the completion of exercise programs. Modalities of exercise were compared and the use of biologic therapy was reported. DATA SYNTHESIS: After screening 190 abstracts, we selected 26 reports for detailed evaluation and finally investigated 8 trials that assessed a home-based exercise program (2/8), swimming (1/8), Pilates training (1/8), or supervised exercises (4/8), for a total of 331 patients with AS. Four trials included patients receiving antitumor necrosis factor therapy. All trials except one showed a decrease in BASDAI and BASFI with exercise. The weighted mean difference was -0.90 (95% confidence interval, -1.52 to -0.27; I2=69%; P=.005) for the BASDAI and -0.72 (95% confidence interval, -1.03 to -0.40; I2=0%; P<.00001) for the BASFI in favor of exercise programs. CONCLUSIONS: Despite the small number of patients and the heterogeneity of exercise programs in the RCTs included in this meta-analysis, its results support the potential of exercise programs to improve disease activity and body function in AS.
OBJECTIVE: To assess the effectiveness of exercise programs on disease activity and function in ankylosing spondylitis (AS) by a systematic review and meta-analysis of randomized controlled trials (RCTs). DATA SOURCES: Medline via PubMed and Cochrane Library. STUDY SELECTION: Reports of RCTs examining the effectiveness of exercise programs for AS published up to May 2017. DATA EXTRACTION: Outcomes were evolution of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) after the completion of exercise programs. Modalities of exercise were compared and the use of biologic therapy was reported. DATA SYNTHESIS: After screening 190 abstracts, we selected 26 reports for detailed evaluation and finally investigated 8 trials that assessed a home-based exercise program (2/8), swimming (1/8), Pilates training (1/8), or supervised exercises (4/8), for a total of 331 patients with AS. Four trials included patients receiving antitumor necrosis factor therapy. All trials except one showed a decrease in BASDAI and BASFI with exercise. The weighted mean difference was -0.90 (95% confidence interval, -1.52 to -0.27; I2=69%; P=.005) for the BASDAI and -0.72 (95% confidence interval, -1.03 to -0.40; I2=0%; P<.00001) for the BASFI in favor of exercise programs. CONCLUSIONS: Despite the small number of patients and the heterogeneity of exercise programs in the RCTs included in this meta-analysis, its results support the potential of exercise programs to improve disease activity and body function in AS.
Authors: Mariano Tomás Flórez; Raquel Almodóvar; Fernando García Pérez; Ana Belén Rodríguez Cambrón; Loreto Carmona; María Ángeles Pérez Manzanero; Juan Aboitiz Cantalapiedra; Ana Urruticoechea-Arana; Carlos J Rodríguez Lozano; Carmen Castro; Cristina Fernández-Carballido; Eugenio de Miguel; Eva Galíndez; José Luis Álvarez Vega; Juan Carlos Torre Alonso; Luis F Linares; Mireia Moreno; Victoria Navarro-Compán; Xavier Juanola; Pedro Zarco Journal: Rheumatol Int Date: 2018-05-21 Impact factor: 2.631
Authors: Bas Hilberdink; Florus van der Giesen; Thea Vliet Vlieland; Floris van Gaalen; Salima van Weely Journal: Arthritis Care Res (Hoboken) Date: 2020-04-25 Impact factor: 4.794